.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Dow
Accenture
US Department of Justice
Cerilliant
Baxter
Moodys
Argus Health
Queensland Health

Generated: November 23, 2017

DrugPatentWatch Database Preview

Atenolol; chlorthalidone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for atenolol; chlorthalidone and what is the scope of atenolol; chlorthalidone freedom to operate?

Atenolol; chlorthalidone
is the generic ingredient in three branded drugs marketed by Alvogen Malta, Mylan, Nostrum Labs, Pliva, Watson Labs, Mutual Pharm, and Sun Pharm Inds, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-three drug master file entries for atenolol; chlorthalidone. Sixteen suppliers are listed for this compound.

Summary for atenolol; chlorthalidone

Pharmacology for atenolol; chlorthalidone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
ATENOLOL AND CHLORTHALIDONE
atenolol; chlorthalidone
TABLET;ORAL073665-001Jul 2, 1992ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
ATENOLOL AND CHLORTHALIDONE
atenolol; chlorthalidone
TABLET;ORAL074203-002Oct 31, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
Mutual Pharm
ATENOLOL AND CHLORTHALIDONE
atenolol; chlorthalidone
TABLET;ORAL073581-001Apr 29, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
TENORETIC 100
atenolol; chlorthalidone
TABLET;ORAL018760-001Jun 8, 1984ABRXYesYes► Subscribe► Subscribe► Subscribe
Nostrum Labs
ATENOLOL AND CHLORTHALIDONE
atenolol; chlorthalidone
TABLET;ORAL074404-002May 14, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
ATENOLOL AND CHLORTHALIDONE
atenolol; chlorthalidone
TABLET;ORAL072302-001May 31, 1990ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
ATENOLOL AND CHLORTHALIDONE
atenolol; chlorthalidone
TABLET;ORAL073665-002Jul 2, 1992ABRXNoNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
TENORETIC 50
atenolol; chlorthalidone
TABLET;ORAL018760-002Jun 8, 1984ABRXYesNo► Subscribe► Subscribe► Subscribe
Mylan
ATENOLOL AND CHLORTHALIDONE
atenolol; chlorthalidone
TABLET;ORAL074203-001Oct 31, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
ATENOLOL AND CHLORTHALIDONE
atenolol; chlorthalidone
TABLET;ORAL072301-001May 31, 1990ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: atenolol; chlorthalidone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen Malta
TENORETIC 100
atenolol; chlorthalidone
TABLET;ORAL018760-001Jun 8, 1984► Subscribe► Subscribe
Alvogen Malta
TENORETIC 50
atenolol; chlorthalidone
TABLET;ORAL018760-002Jun 8, 1984► Subscribe► Subscribe
Alvogen Malta
TENORETIC 50
atenolol; chlorthalidone
TABLET;ORAL018760-002Jun 8, 1984► Subscribe► Subscribe
Alvogen Malta
TENORETIC 50
atenolol; chlorthalidone
TABLET;ORAL018760-002Jun 8, 1984► Subscribe► Subscribe
Alvogen Malta
TENORETIC 100
atenolol; chlorthalidone
TABLET;ORAL018760-001Jun 8, 1984► Subscribe► Subscribe
Alvogen Malta
TENORETIC 100
atenolol; chlorthalidone
TABLET;ORAL018760-001Jun 8, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Julphar
Fuji
Cantor Fitzgerald
Deloitte
Dow
Daiichi Sankyo
UBS
Federal Trade Commission
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot